Giovanni Targher

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Francesco Bellinato

University of Verona

ITALY

View details

Giampiero Girolomoni

ITALY

View details

Alessandro Mantovani

ITALY

View details

Philip Newsome

University of Birmingham

UNITED KINGDOM

View details

Norbert Stefan

GERMANY

View details

Federico Ravaioli

ITALY

View details

Christopher D Byrne

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanni Targher

Research Interests

Explore related searches

Contact this professor

Articles (21)

Response to Comment on Mantovani et al. Sodium–Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies. Diabetes Care 2025;48:1042–1052

Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring

Glucagon‐Like Peptide‐1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta‐Analysis of Randomised Controlled Trials

Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis

Metabolic Dysfunction–Associated Steatotic Liver Disease

Lessons from incretin-based therapy in MASH and obesity

Sodium–Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies

Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study

Associations of lower values of peak oxygen uptake and handgrip strength with a smaller liver volume

Not all fat is alike in MASLD

Relationship between <i>Helicobacter pylori</i> infection and risk of metabolic <scp>dysfunction‐associated</scp> steatotic liver disease: An updated meta‐analysis

Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis

Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals

Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people?

Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study

Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis

Editorial: Recent advances in fibrosis assessment for metabolic dysfunction‐associated fatty liver disease–Authors' reply

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure

Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stages

Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle‐aged individuals with metabolic dysfunction

Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: A panel-data analysis

Collaborators (7)

Francesco Bellinato

Giampiero Girolomoni

Alessandro Mantovani

Philip Newsome

Norbert Stefan

Federico Ravaioli

Christopher D Byrne

Make your next move.